The significance of cyclic AMP and cyclic GMP in cancer treatment
- 31 March 1979
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 6 (1) , 1-15
- https://doi.org/10.1016/s0305-7372(79)80056-0
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Saccharin inhibits guanylate cyclase activity: Possible relationship to carcinogenesisBiochemical and Biophysical Research Communications, 1978
- The positive control of cell proliferation by the interplay of calcium ions and cyclic nucleotides. A reviewIn Vitro Cellular & Developmental Biology - Plant, 1976
- Binding of cyclic nucleotides with soluble proteins increases in “differentiated” neuroblastoma cells in cultureBiochemical and Biophysical Research Communications, 1975
- The role of cAMP on neoplastic cell growth and regression. III. Altered cAMP-binding in DBcAMP-unresponsive walker 256 mammary carcinomaBiochemical and Biophysical Research Communications, 1975
- Studies on neutral esters of cyclic AMPBiochemical and Biophysical Research Communications, 1973
- The adenyl cyclase system and carcinogenesis: Decreased responsiveness of mouse epidermis to isoproterenol after 3,4-benzpyrene treatmentBiochemical and Biophysical Research Communications, 1973
- Increased cyclic AMP levels in malignant hepatic nodules of ethionine treated ratsBiochemical and Biophysical Research Communications, 1972
- Cyclic AMP in cultured human lymphoid cells: Relationship to mitosisBiochemical and Biophysical Research Communications, 1972
- Supression of normal and enhanced tumour growth in rats by agents interfering with intracellular cyclic nucleotidesLife Sciences, 1972
- Cyclic AMP levels in fibroblasts: Relationship to growth rate and contact inhibition of growthBiochemical and Biophysical Research Communications, 1971